Dyslipidemia in Shanghai, China

Preventive Medicine

Volumn 51, Issue 5, 2010, Pages 412-415

  Wu, Jia Yu ^a   Duan, Xiao Yan ^a   Li, Lui ^b   Dai, Fei ^a   Li, Yan Yun ^b   Li, Xing Jian ^b   Fan, Jian Gao ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b Shanghai Center for Disease Control and Prevention   (China)

Author keywords

Dyslipidemia; General population; Hypercholesterolemia; Hypertriglyceridemia; Obesity; Prevalence

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ABDOMINAL OBESITY; ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; BODY MASS; CHINA; CHOLESTEROL BLOOD LEVEL; CLUSTER ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DYSLIPIDEMIA; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; HYPERTRIGLYCERIDEMIA; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; RURAL POPULATION; SEX DIFFERENCE; TRIACYLGLYCEROL BLOOD LEVEL; URBAN POPULATION; WAIST CIRCUMFERENCE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHINA; CHOLESTEROL; CITIES; CROSS-SECTIONAL STUDIES; DYSLIPIDEMIAS; FEMALE; HUMANS; LIPIDS; LIPOPROTEINS, HDL; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; RURAL POPULATION; TRIGLYCERIDES; URBAN POPULATION; YOUNG ADULT;

EID: 77958176735     PISSN: 00917435     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ypmed.2010.08.013     Document Type: Article

References (30)

1. Anuurad E., Shiwaku K., Nogi A., et al. The new BMI criteria for Asians by the regional office for the western pacific region of WHO are suitable for screening of overweight to prevent metabolic syndrome in elder Japanese workers. J. Occup. Health 2003, 45(6):335-343.
2. Arnett D.K., McGovern P.G., Jacobs D.R., et al. Fifteen-year trends in cardiovascular risk factors (1980-1982 through 1995-1997): the Minnesota Heart Survey. Am. J. Epidemiol. 2002, 156(10):929-935.
3. Azizi F., Rahmani M., Emami H., et al. Cardiovascular risk factors in an Iranian urban population: Tehran lipid and glucose study (phase 1). Soz. Praventivmed. 2002, 47(6):408-426.
4. Barbagallo C.M., Polizzi F., Severino M., et al. Distribution of risk factors, plasma lipids, lipoproteins and dyslipidemia in a small Mediterranean island: the Ustica Project. Nutr. Metab. Cardiovasc. Dis. 2002, 12(5):267-274.
5. Cannon C.P. Mixed dyslipidemia, metabolic syndrome, diabetes mellitus, and cardiovascular disease: clinical implications. Am. J. Cardiol. 2008, 102(12A):5L-9L.
6. Castelli W.P. Lipids, risk factors and ischaemic heart disease. Atherosclerosis 1996, 124(Suppl):1S-9S.
7. Chang H.Y., Yeh W.T., Chang Y.H., Tsai K.S., Pan W.H. Prevalence of dyslipidemia and mean blood lipid values in Taiwan: results from the Nutrition and Health Survey in Taiwan (NAHSIT, 1993-1996). Chin. J. Physiol. 2002, 45(4):187-197.
8. Elisaf M. Multiple risk factors in cardiovascular disease-fifth international symposium. 28-31 October 1999, Venice, Italy. I. Drugs 2000, 3(2):156-157.
9. Erem C., Hacihasanoglu A., Deger O., Kocak M., Topbas M. Prevalence of dyslipidemia and associated risk factors among Turkish adults: Trabzon lipid study. Endocrine 2008, 34(1-3):36-51.
10. Fan J.G., Peng Y.D. Metabolic syndrome and non-alcoholic fatty liver disease: Asian definitions and Asian studies. Hepatobiliary Pancreat. Dis. Int. 2007, 6(4):572-578.
11. Fan J.G., Zhu J., Li X.J., et al. Prevalence of and risk factors for fatty liver in a general population of Shanghai, China. J. Hepatol. 2005, 43(3):508-514.
12. Fan J.G., Cai X.B., Li L., Li X.J., Dai F., Zhu J. Alcohol consumption and metabolic syndrome among Shanghai adults: a randomized multistage stratified cluster sampling investigation. World J. Gastroenterol. 2008, 14(15):2418-2424.
13. Girard-Mauduit S. The lipid triad, or how to reduce residual cardiovascular risk?. Ann. Endocrinol. (Paris) 2010, 71(2):89-94.
14. Gregg E.W. Are children the future of type 2 diabetes prevention?. N Engl J. Med. 2010, 362(6):548-550.
15. Chinese Guidelines on Prevention and Treatment of Dyslipidemia in Adults. Zhonghua Xin Xue Guan Bing Za Zhi 2007, 35(5):390-419. Joint Committee for Developing Chinese Guidelines on Prevention and Treatment of Dyslipidemia in Adults, (in Chinese).
16. Laakso M. Lipids in type 2 diabetes. Semin. Vasc. Med. 2002, 2(1):59-66.
17. Li L.M., Rao K.Q., Kong L.Z., et al. A description on the Chinese national nutrition and health survey in 2002. Zhonghua Liu Xing Bing Xue Za Zhi 2005, 26(7):478-484. (in Chinese).
18. Li Z., Yang R., Xu G., Xia T. Serum lipid concentrations and prevalence of dyslipidemia in a large professional population in Beijing. Clin. Chem. 2005, 51(1):144-150.
19. Lowden J.A. New guidelines from the National Cholesterol Education Program: what is the impact on risk assessment?. J. Insur. Med. 2002, 34(1):26-30.
20. Marchesini G., Forlani G., Cerrelli F., et al. WHO and ATP Sh{cyrillic} proposals for the definition of the metabolic syndrome in patients with type 2 diabetes. Diabet. Med. 2004, 21(4):383-387.
21. Okayama A., Ueshima H., Marmot M.G., et al. Changes in total serum cholesterol and other risk factors for cardiovascular disease in Japan, 1980-1989. Int. J. Epidemiol. 1993, 22(6):1038-1047.
22. Primatesta P., Poulter N.R. Lipid concentrations and the use of lipid lowing drugs: evidence from a national cross sectional survey. B.M.J. 2000, 321(7272):1322-1325.
23. The World Health Organization Diet, nutrition, and the prevention of chronic diseases: report of a WHO Study Group. World Health Organ. Tech. Rep. Ser. 1990, 797(1):1-204.
24. Vartiainen E., Jousilahti P., Alfthan G., et al. Cardiovascular risk factor changes in Finland, 1972-1997. Int. J. Epidemiol. 2000, 29(1):49-56.
25. Wang S.H., Sun Z.L., Ruan X.Z., et al. Dyslipidaemia among diabetic patients with ischemic stroke in a Chinese hospital. Chin. Med. J. (Engl.) 2009, 122(21):2567-2572.
26. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004, 363(9403):157-163. WHO expert consultation.
27. Yu Z., Lin X., Haas J.D., et al. Obesity related metabolic abnormalities: distribution and geographic differences among middle-aged and older Chinese populations. Prev. Med. 2009, 48(3):272-278.
28. Zhao W.H., Zhang J., You Y., et al. Epidemiologic characteristics of dyslipidemia in people aged 18 years and over in China. Chin. J. Prev. Med. 2005, 39(5):306-310. (in Chinese).
29. Zhao W.H., Zhang J., Zhai Y., et al. Blood lipid profile and prevalence of dyslipidemia in Chinese adults. Biomed. Environ. Sci. 2007, 20(4):329-335.
30. Zhou B., Rao X., Dennis B.H., et al. The relationship between dietary factors and serum lipids in Chinese urban and rural populations of Beijing and Guangzhou. PRC-USA Cardiovascular and Cardiopulmonary Research Group. Int. J. Epidemiol. 1995, 24(3):528-534.